• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Urosepsis-A Literature Review.尿路脓毒症——文献综述。
Medicina (Kaunas). 2021 Aug 25;57(9):872. doi: 10.3390/medicina57090872.
2
Diagnosis and management for urosepsis.尿脓毒症的诊断和治疗。
Int J Urol. 2013 Oct;20(10):963-70. doi: 10.1111/iju.12200. Epub 2013 May 29.
3
[Research advance in urosepsis].[尿脓毒症的研究进展]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019 Apr 28;44(4):455-460. doi: 10.11817/j.issn.1672-7347.2019.04.018.
4
Management of Urosepsis in 2018.2018 年尿脓毒症的处理。
Eur Urol Focus. 2019 Jan;5(1):5-9. doi: 10.1016/j.euf.2018.11.003. Epub 2018 Nov 15.
5
Retrospective Study of the Etiology, Laboratory Findings, and Management of Patients with Urinary Tract Infections and Urosepsis from a Urology Center in Silesia, Southern Poland Between 2017 and 2020.回顾性研究 2017 年至 2020 年间波兰南部西里西亚地区一家泌尿科中心的尿路感染和尿脓毒症患者的病因、实验室结果和治疗方法。
Med Sci Monit. 2022 Mar 25;28:e935478. doi: 10.12659/MSM.935478.
6
[Urosepsis in Geriatric Patients].老年患者的尿脓毒症
Aktuelle Urol. 2016 Feb;47(1):54-9. doi: 10.1055/s-0041-106184. Epub 2016 Feb 25.
7
Urosepsis--from the view of the urologist.尿脓毒症——泌尿科医生的观点。
Int J Antimicrob Agents. 2011 Dec;38 Suppl:51-7. doi: 10.1016/j.ijantimicag.2011.09.007. Epub 2011 Oct 10.
8
Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.抗菌药物的药代动力学特征与尿脓毒症的优化治疗
Clin Pharmacokinet. 2007;46(4):291-305. doi: 10.2165/00003088-200746040-00003.
9
An update on classification and management of urosepsis.泌尿道脓毒症的分类与管理更新
Curr Opin Urol. 2017 Mar;27(2):133-137. doi: 10.1097/MOU.0000000000000364.
10
Optimal management of urosepsis from the urological perspective.从泌尿外科角度看尿脓毒症的最佳管理
Int J Antimicrob Agents. 2007 Nov;30(5):390-7. doi: 10.1016/j.ijantimicag.2007.06.027. Epub 2007 Aug 28.

引用本文的文献

1
Risk factors for urosepsis following ureteroscopic lithotripsy: a systematic review and meta-analysis.输尿管镜碎石术后尿脓毒症的危险因素:一项系统评价和荟萃分析
Front Surg. 2025 Jun 19;12:1603311. doi: 10.3389/fsurg.2025.1603311. eCollection 2025.
2
Iron uptake by Escherichia coli in urinary tract infections and urosepsis.大肠杆菌在尿路感染和脓毒症中的铁摄取
PLoS One. 2025 Jun 26;20(6):e0326251. doi: 10.1371/journal.pone.0326251. eCollection 2025.
3
Application of a Two-Phase Experiment Design and Optimization Method to Formulate Ciprofloxacin-Loaded Bovine Serum Albumin Nanoparticles with High-Entrapment Efficiency for Targeting Urinary Tract Infections.应用两阶段实验设计与优化方法制备用于靶向治疗尿路感染的高包封率环丙沙星负载牛血清白蛋白纳米粒
AAPS PharmSciTech. 2025 May 2;26(5):122. doi: 10.1208/s12249-025-03115-6.
4
Recurrent Urosepsis Following Stent Removal for Ureteral Stones: A Case Report.输尿管结石支架取出术后复发性泌尿道感染:一例报告
Case Rep Urol. 2025 Apr 23;2025:5547651. doi: 10.1155/criu/5547651. eCollection 2025.
5
Constructing a machine learning model for systemic infection after kidney stone surgery based on CT values.基于CT值构建肾结石手术后全身感染的机器学习模型。
Sci Rep. 2025 Feb 5;15(1):4327. doi: 10.1038/s41598-025-88704-y.
6
Culture and amplification-free nanopore sequencing for rapid detection of pathogens and antimicrobial resistance genes from urine.基于文化和扩增的无纳米孔测序技术快速检测尿液中的病原体和抗菌药物耐药基因。
Eur J Clin Microbiol Infect Dis. 2024 Nov;43(11):2177-2190. doi: 10.1007/s10096-024-04929-1. Epub 2024 Sep 16.
7
Beyond Blood Clotting: The Many Roles of Platelet-Derived Extracellular Vesicles.超越血液凝固:血小板衍生细胞外囊泡的多种作用。
Biomedicines. 2024 Aug 14;12(8):1850. doi: 10.3390/biomedicines12081850.
8
Diagnostic performance of machine learning in systemic infection following percutaneous nephrolithotomy and identification of associated risk factors.机器学习在经皮肾镜取石术后全身感染中的诊断性能及相关危险因素的识别
Heliyon. 2024 May 9;10(10):e30956. doi: 10.1016/j.heliyon.2024.e30956. eCollection 2024 May 30.
9
Nomogram predictive model for in-hospital mortality risk in elderly ICU patients with urosepsis.老年脓毒症性泌尿系统感染重症监护病房患者院内死亡风险的列线图预测模型
BMC Infect Dis. 2024 Apr 26;24(1):442. doi: 10.1186/s12879-024-09319-8.
10
Risk factors of concurrent urinary sepsis in patients with diabetes mellitus comorbid with upper urinary tract calculi.糖尿病合并上尿路结石患者并发尿源性脓毒症的危险因素
World J Diabetes. 2023 Sep 15;14(9):1403-1411. doi: 10.4239/wjd.v14.i9.1403.

本文引用的文献

1
The Weekend Effect in Older Adult Urosepsis Admissions.老年尿脓毒症患者的周末效应。
Med Care. 2020 Jan;58(1):65-69. doi: 10.1097/MLR.0000000000001225.
2
Ureteric stent versus percutaneous nephrostomy for acute ureteral obstruction - clinical outcome and quality of life: a bi-center prospective study.输尿管支架与经皮肾造瘘术治疗急性输尿管梗阻的比较 - 临床结果和生活质量:一项双中心前瞻性研究。
BMC Urol. 2019 Aug 28;19(1):79. doi: 10.1186/s12894-019-0510-4.
3
Sepsis: The evolution in definition, pathophysiology, and management.脓毒症:定义、病理生理学及管理的演变
SAGE Open Med. 2019 Mar 21;7:2050312119835043. doi: 10.1177/2050312119835043. eCollection 2019.
4
Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study.经皮肾造瘘术与输尿管支架治疗输尿管结石继发肾积水:对自发性结石排出和健康相关生活质量的影响——一项前瞻性研究。
Urolithiasis. 2019 Dec;47(6):567-573. doi: 10.1007/s00240-018-1078-2. Epub 2018 Sep 15.
5
The procalcitonin/albumin ratio as an early diagnostic predictor in discriminating urosepsis from patients with febrile urinary tract infection.降钙素原/白蛋白比值作为鉴别泌尿道脓毒症与发热性尿路感染患者的早期诊断预测指标。
Medicine (Baltimore). 2018 Jul;97(28):e11078. doi: 10.1097/MD.0000000000011078.
6
Clinical Utility and Measurement of Procalcitonin.降钙素原的临床应用与检测
Clin Biochem Rev. 2017 Apr;38(2):59-68.
7
Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis.早期目标导向治疗脓毒性休克的患者水平荟萃分析。
N Engl J Med. 2017 Jun 8;376(23):2223-2234. doi: 10.1056/NEJMoa1701380. Epub 2017 Mar 21.
8
Management of Sepsis and Septic Shock.脓毒症和脓毒性休克的管理
JAMA. 2017 Feb 28;317(8):847-848. doi: 10.1001/jama.2017.0131.
9
Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study.中段前肾上腺髓质素(MR-proADM),危重症患者液体正平衡的标志物:ENVOL研究结果
Crit Care. 2016 Nov 9;20(1):363. doi: 10.1186/s13054-016-1540-x.
10
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义(脓毒症-3)》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.

尿路脓毒症——文献综述。

The Urosepsis-A Literature Review.

机构信息

Clinical Emergency County Hospital "Sf. Ap. Andrei", 800578 Galați, Romania.

Faculty of Medicine and Pharmacy, Dunarea de Jos University, 800008 Galați, Romania.

出版信息

Medicina (Kaunas). 2021 Aug 25;57(9):872. doi: 10.3390/medicina57090872.

DOI:10.3390/medicina57090872
PMID:34577795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8468212/
Abstract

Urosepsis is a very serious condition with a high mortality rate. The immune response is in the center of pathophysiology. The therapeutic management of these patients includes surgical treatment of the source of infection, antibiotic therapy and life support. The management of this pathology is multidisciplinary and requires good collaboration between the urology, intensive care, imaging and laboratory medicine departments. An imbalance of pro and anti-inflammatory cytokines produced during sepsis plays an important role in pathogenesis. The study of cytokines in sepsis has important implications for understanding pathophysiology and for development of other therapeutic solutions. If not treated adequately, urosepsis may lead to serious septic complications and organ sequelae, even to a lethal outcome.

摘要

尿脓毒症是一种非常严重的疾病,死亡率很高。免疫反应是发病机制的核心。这些患者的治疗管理包括感染源的手术治疗、抗生素治疗和生命支持。这种病理的管理是多学科的,需要泌尿科、重症监护、影像学和实验室医学等部门之间的良好协作。在脓毒症期间产生的促炎和抗炎细胞因子的失衡在发病机制中起着重要作用。对脓毒症中细胞因子的研究对理解发病机制和开发其他治疗方法具有重要意义。如果治疗不充分,尿脓毒症可能导致严重的脓毒症并发症和器官后遗症,甚至导致致命后果。